Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jalil Rashedi

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Endocrine, Metabolic & Immune Disorders Drug Targets|May 6, 2020
IFN-γ and TNF-α Gene Polymorphisms in Multiple Sclerosis Patients in Northwest IranMohammad Asgharzadeh, Nima Najafi-Ghalehlou, Behroz M Poor, et al.
Journal of Physiology and Biochemistry|June 28, 2018
FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic ratsDavoud Sanajou, Amir Ghorbani Haghjo, Hassan Argani, et al.
Iranian Journal of Basic Medical Sciences|June 7, 2019
Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axisZahra Ashrafi Jigheh, Amir Ghorbani Haghjo, Hassan Argani, et al.
Indian Journal of Clinical Biochemistry : IJCB|February 20, 2020
Empagliflozin Attenuates Renal and Urinary Markers of Tubular Epithelial Cell Injury in Streptozotocin-induced Diabetic RatsZahra Ashrafi Jigheh, Amir Ghorbani Haghjo, Hassan Argani, et al.
Iranian Journal of Allergy, Asthma, and Immunology|April 11, 2025
Association between IFN-γ +874T/A SNP and COVID-19 SeveritySeyyed Amin Seyyed Rezaei, Vahid Asgharzadeh, Behroz Mahdavi Poor, et al.
European Journal of Pharmacology|November 6, 2018
Reduction of renal tubular injury with a RAGE inhibitor FPS-ZM1, valsartan and their combination in streptozotocin-induced diabetes in the ratDavoud Sanajou, Amir Ghorbani Haghjo, Hassan Argani, et al.
Advanced Pharmaceutical Bulletin|October 9, 2019
Anti-tumor Effect of Quercetin Loaded Chitosan Nanoparticles on Induced Colon Cancer in Wistar RatsJalil Rashedi, Amir Ghorbani Haghjo, Mehran Mesgari Abbasi, et al.
Tuberculosis and Respiratory Diseases|June 25, 2020
False-Positive Mycobacterium tuberculosis Detection: Ways to Prevent Cross-ContaminationMohammad Asgharzadeh, Mahdi Asghari Ozma, Jalil Rashedi, et al.
Infectious Disorders Drug Targets|September 4, 2024
Host Risk Factors for TuberculosisVahid Asgharzadeh, Seyyed Amin Seyyed Rezaei, Mohammad Asgharzadeh, et al.
Lung|June 17, 2019
Laboratory Cross-Contamination of Mycobacterium tuberculosis: A Systematic Review and Meta-analysisAleksandra Barac, Hannah Karimzadeh-Esfahani, Mahya Pourostadi, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Endocrine, Metabolic & Immune Disorders Drug Targets|May 6, 2020
IFN-γ and TNF-α Gene Polymorphisms in Multiple Sclerosis Patients in Northwest IranMohammad Asgharzadeh, Nima Najafi-Ghalehlou, Behroz M Poor, et al.
Journal of Physiology and Biochemistry|June 28, 2018
FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic ratsDavoud Sanajou, Amir Ghorbani Haghjo, Hassan Argani, et al.
Iranian Journal of Basic Medical Sciences|June 7, 2019
Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axisZahra Ashrafi Jigheh, Amir Ghorbani Haghjo, Hassan Argani, et al.
Indian Journal of Clinical Biochemistry : IJCB|February 20, 2020
Empagliflozin Attenuates Renal and Urinary Markers of Tubular Epithelial Cell Injury in Streptozotocin-induced Diabetic RatsZahra Ashrafi Jigheh, Amir Ghorbani Haghjo, Hassan Argani, et al.
Iranian Journal of Allergy, Asthma, and Immunology|April 11, 2025
Association between IFN-γ +874T/A SNP and COVID-19 SeveritySeyyed Amin Seyyed Rezaei, Vahid Asgharzadeh, Behroz Mahdavi Poor, et al.
European Journal of Pharmacology|November 6, 2018
Reduction of renal tubular injury with a RAGE inhibitor FPS-ZM1, valsartan and their combination in streptozotocin-induced diabetes in the ratDavoud Sanajou, Amir Ghorbani Haghjo, Hassan Argani, et al.
Advanced Pharmaceutical Bulletin|October 9, 2019
Anti-tumor Effect of Quercetin Loaded Chitosan Nanoparticles on Induced Colon Cancer in Wistar RatsJalil Rashedi, Amir Ghorbani Haghjo, Mehran Mesgari Abbasi, et al.
Tuberculosis and Respiratory Diseases|June 25, 2020
False-Positive Mycobacterium tuberculosis Detection: Ways to Prevent Cross-ContaminationMohammad Asgharzadeh, Mahdi Asghari Ozma, Jalil Rashedi, et al.
Infectious Disorders Drug Targets|September 4, 2024
Host Risk Factors for TuberculosisVahid Asgharzadeh, Seyyed Amin Seyyed Rezaei, Mohammad Asgharzadeh, et al.
Lung|June 17, 2019
Laboratory Cross-Contamination of Mycobacterium tuberculosis: A Systematic Review and Meta-analysisAleksandra Barac, Hannah Karimzadeh-Esfahani, Mahya Pourostadi, et al.
Pageof 6